Fluarix, inactivated split-virus influenza vaccine

Expert Opinion on Biological Therapy
G W Rose, C L Cooper

Abstract

Influenza is a potentially fatal respiratory infection resulting from several influenza virus strains. It causes annual epidemics of disease for which vaccination is the cornerstone of public health policy. The inadequacies of vaccine supply in the US during the 2004 influenza season revealed the deficiencies of current vaccine development and delivery. One outcome of this was the accelerated approval of an inactivated split-virus influenza vaccine, Fluarix. This paper reviews the immunogenicity and reactogenicity of this vaccine, and makes recommendations for the incorporation of Fluarix into the public health framework alongside other similar vaccines. Other directions to explore in an effort to secure future vaccine supply are considered.

References

Jun 1, 1987·American Journal of Public Health·K J Lui, A P Kendal
Jan 1, 1993·Vaccine·D L Skea, B H Barber
Dec 1, 1993·American Journal of Public Health·K M SullivanI M Longini
Feb 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E A BlumbergF G Hayden
Jan 9, 1998·Drugs·A M Palache
Feb 7, 1998·American Journal of Public Health·L SimonsenL B Schonberger
Jan 24, 1998·Epidemiology and Infection·A J ColquhounN T Raymond
Mar 12, 1998·Infectious Disease Clinics of North America·N J Cox, K Fukuda
Dec 17, 1998·The New England Journal of Medicine·T LaskyR T Chen
Feb 26, 1999·Leukemia & Lymphoma·L B Brydak, M Całbecka
Mar 30, 1999·Transplantation·G BurbachP Neuhaus
Mar 18, 2000·The Journal of Infectious Diseases·L SimonsenN J Cox
May 3, 2002·Reviews in Medical Virology·Ralf WagnerHans-Dieter Klenk
Dec 5, 2002·The Journal of Allergy and Clinical Immunology·Robert S Zeiger
Dec 13, 2002·Vaccine·Alessandro R ZanettiElisabetta Tanzi
Jan 9, 2003·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Apr 11, 2003·Vaccine·Catherine Gerdil
Apr 9, 2004·The Pediatric Infectious Disease Journal·Güler KanraNicola Principi
Apr 22, 2004·The Journal of Allergy and Clinical Immunology·Nicola A HananiaUNKNOWN American Lung Association Asthma Clinical Research Centers
Apr 29, 2004·Journal of Clinical Immunology·Lidia B BrydakRoma Rokicka-Milewska
May 28, 2004·Virus Research·Xiyan XuAlexander Klimov
May 28, 2004·Virus Research·Julia RomanovaAndrej Egorov
Sep 16, 2004·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Nov 5, 2004·The New England Journal of Medicine·Robert B BelsheGary Dubin
Nov 5, 2004·The New England Journal of Medicine·Richard T KenneyGregory M Glenn
Nov 27, 2004·The New England Journal of Medicine·Curtis L CooperD W Cameron
Mar 23, 2005·Vaccine·Eva NegriCarlo La Vecchia
Jun 1, 2005·Pediatric Clinics of North America·H Cody Meissner
Jun 22, 2005·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Heidi I GröhnOlli H J Gröhn
Sep 9, 2005·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Patrick A HelmRaimond L Winslow
Oct 3, 2006·Human Vaccines·John J TreanorBruce L Innis

❮ Previous
Next ❯

Citations

May 2, 2009·Archives of Pharmacal Research·Kyungdong BaeByungki Hur
May 21, 2009·Influenza and Other Respiratory Viruses·Benoit BarasEmmanuel Hanon
Jun 2, 2016·Human Vaccines & Immunotherapeutics·Nicola Luigi BragazziGiancarlo Icardi
Jan 27, 2007·The Cochrane Database of Systematic Reviews·E PucciC Taus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.